Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 3
1996 5
1997 1
1998 1
1999 1
2001 1
2003 2
2004 2
2006 2
2007 2
2008 4
2009 1
2010 3
2011 1
2012 3
2013 1
2014 3
2015 4
2016 2
2017 1
2018 3
2020 5
2021 6
2022 4
2023 5
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE; PD MED Collaborative Group. Gray R, et al. JAMA Neurol. 2022 Feb 1;79(2):131-140. doi: 10.1001/jamaneurol.2021.4736. JAMA Neurol. 2022. PMID: 34962574 Free PMC article. Clinical Trial.
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
Dewan R, Chia R, Ding J, Hickman RA, Stein TD, Abramzon Y, Ahmed S, Sabir MS, Portley MK, Tucci A, Ibáñez K, Shankaracharya FNU, Keagle P, Rossi G, Caroppo P, Tagliavini F, Waldo ML, Johansson PM, Nilsson CF; American Genome Center (TAGC); FALS Sequencing Consortium; Genomics England Research Consortium; International ALS/FTD Genomics Consortium (iAFGC); International FTD Genetics Consortium (IFGC); International LBD Genomics Consortium (iLBDGC); NYGC ALS Consortium; PROSPECT Consortium; Rowe JB, Benussi L, Binetti G, Ghidoni R, Jabbari E, Viollet C, Glass JD, Singleton AB, Silani V, Ross OA, Ryten M, Torkamani A, Tanaka T, Ferrucci L, Resnick SM, Pickering-Brown S, Brady CB, Kowal N, Hardy JA, Van Deerlin V, Vonsattel JP, Harms MB, Morris HR, Ferrari R, Landers JE, Chiò A, Gibbs JR, Dalgard CL, Scholz SW, Traynor BJ. Dewan R, et al. Neuron. 2021 Feb 3;109(3):448-460.e4. doi: 10.1016/j.neuron.2020.11.005. Epub 2020 Nov 26. Neuron. 2021. PMID: 33242422 Free PMC article.
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
PD Med Collaborative Group; Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. PD Med Collaborative Group, et al. Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Lancet. 2014. PMID: 24928805 Clinical Trial.
Effects of forces on chromatin.
Amar K, Wei F, Chen J, Wang N. Amar K, et al. APL Bioeng. 2021 Oct 13;5(4):041503. doi: 10.1063/5.0065302. eCollection 2021 Dec. APL Bioeng. 2021. PMID: 34661040 Free PMC article. Review.
Vascular dementia.
Amar K, Wilcock G. Amar K, et al. BMJ. 1996 Jan 27;312(7025):227-31. doi: 10.1136/bmj.312.7025.227. BMJ. 1996. PMID: 8563591 Free PMC article. Review. No abstract available.
Mild cognitive impairment.
Amar K, Ibrahim IR. Amar K, et al. Br J Hosp Med (Lond). 2007 Oct;68(10):526-9. doi: 10.12968/hmed.2007.68.10.27322. Br J Hosp Med (Lond). 2007. PMID: 17974294 Review.
Progressive supranuclear palsy.
Amar K. Amar K. Hosp Med. 2003 Oct;64(10):585-8. doi: 10.12968/hosp.2003.64.10.2321. Hosp Med. 2003. PMID: 14584237 Review.
Parkinson's families project: a UK-wide study of early onset and familial Parkinson's disease.
Towns C, Fang ZH, Tan MMX, Jasaityte S, Schmaderer TM, Stafford EJ, Pollard M, Tilney R, Hodgson M, Wu L, Labrum R, Hehir J, Polke J, Lange LM, Schapira AHV, Bhatia KP; Parkinson’s Families Project (PFP) Study Group; Global Parkinson’s Genetics Program (GP2); Singleton AB, Blauwendraat C, Klein C, Houlden H, Wood NW, Jarman PR, Morris HR, Real R. Towns C, et al. NPJ Parkinsons Dis. 2024 Oct 17;10(1):188. doi: 10.1038/s41531-024-00778-z. NPJ Parkinsons Dis. 2024. PMID: 39420034 Free PMC article.
Improving Conversations about Parkinson's Dementia.
Dobreva I, Thomas J, Marr A, O'Connell R, Roche M, Hannaway N, Dore C, Rose S, Liu K, Bhome R, Baldwin-Jones S, Roberts J, Archibald N, Alston D, Amar K, Edwards E, Foley JA, Haunton VJ, Henderson EJ, Jha A, Lindop F, Magee C, Massey L, Ruiz-Mendoza E, Mohamed B, Patterson K, Ramaswamy B, Schrag A, Silverdale M, Suárez-González A, Subramanian I, Foltynie T, Williams-Gray CH, Yarnall AJ, Carroll C, Bale C, Hugill C, Weil RS. Dobreva I, et al. Among authors: amar k. Mov Disord Clin Pract. 2024 Jul;11(7):814-824. doi: 10.1002/mdc3.14054. Epub 2024 May 2. Mov Disord Clin Pract. 2024. PMID: 38696333 Free PMC article.
62 results